Introduction
A gynaecological cancer diagnosis affects not just a woman’s health — it touches every part of her life, her relationships, and her sense of self. Whether it is ovarian, cervical, or uterine cancer, the journey ahead can feel overwhelming. Finding the right medical team — one that combines clinical expertise with genuine sensitivity — makes an enormous difference.
For women across Gujarat seeking gynaecological cancer treatment in Ahmedabad, Zanish Cancer Hospital offers a dedicated, multidisciplinary approach to the full spectrum of gynaecological cancers. From early-stage surgical intervention to advanced systemic therapy, our team is committed to delivering evidence-based care with compassion and respect for every patient’s individual needs.
This article covers the three most commonly diagnosed gynaecological cancers — ovarian, cervical, and uterine — including their symptoms, how they are diagnosed, what treatment involves, and what patients in Ahmedabad and across Gujarat can expect from specialist oncological care. Our aim is to give you clear, trustworthy information to support informed decision-making at every stage of your journey.
Ovarian Cancer — Symptoms, Stages & Treatment
What Is Ovarian Cancer?
Ovarian cancer begins in the ovaries — the female reproductive organs responsible for producing eggs and hormones. It is frequently called a “silent cancer” because early symptoms are subtle and easily attributed to other common conditions. As a result, approximately 70–75% of ovarian cancer cases in India are diagnosed at an advanced stage (Stage III or IV).
The most common type is epithelial ovarian cancer, which arises from the outer surface of the ovary. Other types include germ cell tumours and sex cord-stromal tumours, which tend to occur in younger women and often carry a better prognosis.
Symptoms of Ovarian Cancer
Women should be aware of the following persistent symptoms, particularly if they are new and occur frequently:
- Abdominal bloating or swelling
- Pelvic or abdominal pain or pressure
- Feeling full quickly when eating, or difficulty eating
- Frequent or urgent urination
- Unexplained fatigue
- Changes in bowel habits
- Unexplained weight loss or gain
These symptoms are non-specific, meaning they overlap with many benign conditions. However, when they are persistent (occurring more than 12 times per month), an evaluation by a specialist is strongly advised.
Diagnosis
Diagnostic workup typically includes transvaginal ultrasound, CT scan of the abdomen and pelvis, CA-125 blood test (a tumour marker), and in some cases, HE4 testing. Definitive diagnosis is made through histopathological examination of surgically obtained tissue.
Treatment of Ovarian Cancer
Surgery is central to ovarian cancer treatment and serves two purposes: staging the disease and removing as much tumour as possible (cytoreduction or debulking). The goal is to achieve optimal cytoreduction — leaving no visible residual disease — which is one of the strongest predictors of improved survival.
Surgical procedures include:
- Total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH-BSO): Removal of the uterus, both ovaries, and both fallopian tubes.
- Omentectomy: Removal of the omentum (fatty tissue covering the abdominal organs), a common site of spread.
- Lymph node dissection: Pelvic and para-aortic lymph nodes are sampled or removed to accurately stage the disease.
- Peritoneal stripping and bowel resection: In advanced cases, involved peritoneal surfaces or segments of bowel may be removed as part of aggressive debulking.
Following surgery, most patients with epithelial ovarian cancer receive platinum-based chemotherapy — typically carboplatin combined with paclitaxel. For patients with BRCA1/2 mutations or homologous recombination deficiency (HRD), PARP inhibitors (such as olaparib or niraparib) are now used as maintenance therapy and have significantly improved progression-free survival.
Cervical Cancer — Prevention, Detection & Treatment
What Is Cervical Cancer?
Cervical cancer develops in the cells of the cervix — the lower, narrow portion of the uterus that opens into the vagina. It is one of the most preventable cancers, as the vast majority of cases are caused by persistent infection with high-risk strains of Human Papillomavirus (HPV), particularly HPV 16 and 18.
In India, cervical cancer remains the second most common cancer in women, and Gujarat is no exception. Inadequate access to routine cervical screening (Pap smears) and low HPV vaccination rates remain significant challenges, contributing to late-stage diagnoses.
Symptoms of Cervical Cancer
- Abnormal vaginal bleeding — between periods, after intercourse, or after menopause
- Unusual vaginal discharge (watery, bloody, or foul-smelling)
- Pelvic pain or pain during intercourse
- In advanced cases: swelling of the legs, difficulty urinating, or blood in urine or stool
Early-stage cervical cancer is often asymptomatic — which is precisely why regular Pap smear screening (every 3 years from age 21–65) is so important.
Diagnosis
Cervical cancer is diagnosed through colposcopy and biopsy following an abnormal Pap smear result. Staging involves MRI pelvis, CT chest-abdomen-pelvis, and sometimes PET-CT scan. A staging examination under anaesthesia may be performed in select cases.
Treatment of Cervical Cancer
Treatment depends on the stage:
- Stage IA1 (Microinvasive): Cone biopsy or simple hysterectomy. Fertility-sparing options are available in carefully selected cases.
- Stage IA2–IIA: Radical hysterectomy with pelvic lymph node dissection (Wertheim’s hysterectomy) — the standard surgical option for early-stage disease.
- Stage IIB–IVA (Locally Advanced): Concurrent chemoradiation (cisplatin-based chemotherapy combined with external beam radiation and brachytherapy) is the standard of care and can be curative.
- Stage IVB (Metastatic): Systemic chemotherapy, targeted therapy (bevacizumab), and immunotherapy (pembrolizumab for PD-L1 positive or MSI-H tumours) are used.
HPV vaccination — with vaccines such as Gardasil 9 — is strongly recommended for girls and women aged 9–45 years as a preventive measure, and boys can also be vaccinated to reduce transmission.
Uterine (Endometrial) Cancer — Recognition & Surgical Care
What Is Uterine Cancer?
Uterine cancer, most commonly endometrial cancer, begins in the lining of the uterus (endometrium). It is the most commonly diagnosed gynaecological cancer in high-income countries and is increasingly being diagnosed in India, partly due to rising rates of obesity, diabetes, and hormonal imbalances — all established risk factors.
Most endometrial cancers are diagnosed at an early stage because they tend to cause an early, recognisable symptom: postmenopausal vaginal bleeding.
Symptoms
- Abnormal vaginal bleeding — particularly any bleeding after menopause
- Irregular or heavy periods in premenopausal women
- Pelvic pain or pressure
- Watery or blood-tinged vaginal discharge
- Pain during intercourse
Any postmenopausal bleeding must be evaluated promptly. It is not normal and should never be assumed to be benign without investigation.
Risk Factors
- Obesity — the single strongest modifiable risk factor (excess fat tissue produces oestrogen)
- Diabetes mellitus
- Polycystic ovary syndrome (PCOS)
- Nulliparity (never having been pregnant)
- Late menopause (after age 55)
- Long-term use of tamoxifen
- Lynch syndrome (hereditary condition)
- Family history of endometrial or colorectal cancer
Treatment of Uterine Cancer
Surgery is the primary treatment for most stages of endometrial cancer. The standard procedure is total hysterectomy with bilateral salpingo-oophorectomy — removal of the uterus, cervix, both ovaries, and both fallopian tubes — along with pelvic and para-aortic lymph node assessment.
At Zanish Cancer Hospital, minimally invasive laparoscopic or robotic-assisted hysterectomy is offered where clinically appropriate, resulting in smaller incisions, reduced blood loss, faster recovery, and shorter hospital stays compared to open surgery — with equivalent oncological outcomes for early-stage disease.
Following surgery, adjuvant treatment is guided by the pathological risk category:
- Low risk: Surveillance alone.
- Intermediate/High-Intermediate Risk: Vaginal brachytherapy (internal radiation to the vaginal cuff).
- High Risk: External beam radiotherapy, chemotherapy, or combined chemoradiation.
- Advanced/Recurrent Disease: Systemic chemotherapy (carboplatin/paclitaxel), targeted therapy (lenvatinib plus pembrolizumab for MSI-H tumours), or hormonal therapy for low-grade tumours.
Zanish Cancer Hospital's Role in Gynaecological Cancer Care
Zanish Cancer Hospital, led by Dr. Nishant Sanghavi — M.Ch Surgical Oncology (GCRI Ahmedabad), Fellowship in Advanced Laparoscopic Surgical Oncology — provides comprehensive gynaecological oncology surgical services to women across Ahmedabad and Gujarat.
What patients can expect at Zanish:
- Specialised Gynae-Oncology Surgery: From radical hysterectomy and cytoreductive surgery for ovarian cancer to fertility-sparing procedures in appropriate cases, surgical care is delivered with oncological precision.
- Minimally Invasive Approach: Laparoscopic surgical techniques are offered wherever clinically safe and appropriate, prioritising faster recovery and better quality of life.
- Multidisciplinary Tumour Board Reviews: Every gynaecological cancer case is discussed by surgical, medical, and radiation oncologists together — ensuring treatment decisions are comprehensive and personalised.
- Molecular and Biomarker Testing: BRCA testing, HRD profiling, MSI/MMR testing, and PD-L1 assessment are integrated into treatment planning to guide targeted and immunotherapy decisions.
- Compassionate, Woman-Centred Care: Our team understands the unique physical and emotional dimensions of gynaecological cancer treatment. Privacy, dignity, and sensitivity are embedded in every aspect of the patient experience.
- Accessible Care in Ahmedabad: Located in Naranpura, Zanish Cancer Hospital is easily reachable for women from across Gujarat, Rajasthan, and beyond — eliminating the need to travel to distant cities for specialist gynaecological oncology care.
- 24/7 Helpline: Patients and families have round-the-clock access to support from the care team throughout treatment.
Conclusion: Compassionate, Expert Gynaecological Cancer Care in Ahmedabad
Ovarian, cervical, and uterine cancers are serious — but with the right team and timely intervention, many women go on to live full, healthy lives after treatment. The key is early evaluation, accurate staging, and access to a surgeon and oncology team with genuine expertise in gynaecological cancers.
If you or someone you love has been diagnosed, is experiencing concerning symptoms, or wishes to seek a specialist second opinion, Zanish Cancer Hospital is here to support you at every step.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Every patient’s situation is unique. Please consult a qualified gynaecological oncologist for a personalised evaluation, diagnosis, and treatment plan.
Make Appointment
Address
1st Floor, Viva Atelier, Opp. B.D. Patel House, Near Sardar Patel Statue, Behind Sardar Patel Colony, Naranpura, Ahmedabad-380014. (Gujarat) India
Contact Us
+91 7433852300